Allergan, Inc. News Headlines

AGN 
$184.21
*  
0.84
0.46%
Get AGN Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading AGN now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
AstraZeneca's Olaparib Fails to Impress FDA Panel - Analyst Blog
6/26/2014 11:10:00 AM - Zacks.com


Bristol-Myers Up on Nivolumab News - Analyst Blog
6/26/2014 10:45:00 AM - Zacks.com


Bayer Inks Hemophilia Deal with Dimension Therapeutics - Analyst Blog
6/25/2014 4:45:00 PM - Zacks.com


Vertex Pharma Skyrockets on Cystic Fibrosis Drug Trial Results - Analyst Blog
6/25/2014 10:45:00 AM - Zacks.com


Forest Laboratories Reports Positive Data on Viibryd - Analyst Blog
6/24/2014 6:20:00 PM - Zacks.com


AbbVie Raises Outlook amidst Shire Takeover Attempts - Analyst Blog
6/24/2014 4:40:00 PM - Zacks.com


Abbott Labs to Buy Russia-Based Veropharm - Analyst Blog
6/24/2014 4:15:00 PM - Zacks.com


Allergan Rejects Valeant's Deal - Analyst Blog
6/24/2014 3:58:00 PM - Zacks.com


Clovis Oncology Initiates Study on CO-1686 - Analyst Blog
6/24/2014 11:40:00 AM - Zacks.com


Shire Rejects AbbVie's Offer, Shares Up - Analyst Blog
6/23/2014 5:31:00 PM - Zacks.com


TSX Narrows Loss, Down 9 Points Mid-Afternoon As Healthcare Slightly Improves, Miners Remain Strong
6/23/2014 2:18:01 PM - MT Newswires


Who Is Telling The Truth On Fillers: Valeant's CEO Or Allergan's CEO? Is Valeant's Debt A Time-Bomb?
6/23/2014 2:06:00 PM - Seeking Alpha


TSX Down 28 Points at Midday; Healthcare Drives Losses As Valeant Weighs, Miners Gaining on Gold Boost
6/23/2014 12:22:01 PM - MT Newswires


Novo Nordisk Reveals Positive Data on Victoza 3 mg - Analyst Blog
6/23/2014 11:30:00 AM - Zacks.com


Aerie's Upcoming Catalyst - ROCKing The Way To Success
6/23/2014 11:14:00 AM - Seeking Alpha


AstraZeneca's Naloxegol Data Published - Analyst Blog
6/20/2014 6:00:00 PM - Zacks.com


OncoMed's OMP-54F28 on Partial Clinical Hold - Analyst Blog
6/20/2014 3:50:00 PM - Zacks.com


Allergan Should Buy Perrigo For A Tax Inversion; Before Someone Else Does
6/20/2014 3:19:00 PM - Seeking Alpha


Celgene Rises on Yet Another Stock Split - Analyst Blog
6/20/2014 11:30:00 AM - Zacks.com


Valeant Launches Hostile Bid for Allergan - Analyst Blog
6/19/2014 5:50:00 PM - Zacks.com


Midday Update: Stocks Soften Before FOMC Conclusion: Major Averages
6/18/2014 12:30:03 PM - MT Newswires


Valeant Left Important Questions Unanswered; Allergan Shareholders Beware
6/18/2014 12:02:00 PM - Seeking Alpha


Pfizer Ties Up with Cellectis for Cancer Immunotherapy - Analyst Blog
6/18/2014 11:10:00 AM - Zacks.com


Novartis Submits Bexsero to FDA for Marketing Approval - Analyst Blog
6/17/2014 4:47:00 PM - Zacks.com


Glaxo's Promacta Holds Promise - Analyst Blog
6/17/2014 4:45:00 PM - Zacks.com